Adam Evertts
Director of Research - Equity at LifeSci Capital LLC
Adam Evertts active positions
Companies | Position | Start | End |
---|---|---|---|
LifeSci Capital LLC
LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank based in New York, NY. LifeSci Capital LLC provides financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. The company also has a highly regarded team of analysts who generate differentiated, proprietary research and cover companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Dan Alan Wychulis has been the CEO of the company since 2024. | Analyst-Equity | 2018-06-30 | - |
Director of Research - Equity | 2021-08-31 | - |
Career history of Adam Evertts
Former positions of Adam Evertts
Companies | Position | Start | End |
---|---|---|---|
Lifesci Advisors LLC (Research) | Analyst-Equity | 2013-03-31 | 2016-06-30 |
Training of Adam Evertts
Indiana University | Undergraduate Degree |
Princeton University | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Analyst-Equity | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Lifesci Advisors LLC (Research) | Finance |
LifeSci Capital LLC
LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank based in New York, NY. LifeSci Capital LLC provides financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. The company also has a highly regarded team of analysts who generate differentiated, proprietary research and cover companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Dan Alan Wychulis has been the CEO of the company since 2024. | Finance |
- Stock Market
- Insiders
- Adam Evertts
- Experience